Table 1. The OSCC cell lines and the status of Bmi-1, p16INK4A, p53, and HPV infection.
Cells | Tissue origin | Bmi-1a | p16INK4Ab | p53 | HPV status |
---|---|---|---|---|---|
BaP-Tc | gingiva | − | + | Targeted by E6 | +/type 16 |
SCC4d | tongue | + | + | mutant | − |
SCC9d | tongue | + | − | − | − |
SCC15d | tongue | + | − | − | − |
HEp-2d | larynx | + | + | Targeted by E6 | +/type 18 |
1483e | oral | + | + | Targeted by E6 | +/type 18 |
FaDud | pharynx | + | + | Mutant | − |
Tu139f | larynx | + | − | Mutant | − |
RKOg | colorectum | + | − | wild-type | − |
HeLad | cervix | + | + | Targeted by E6 | +/type 18 |
Bmi-1 overexpression was determined based on the RT–PCR and Western blotting results (Figure 1). Positive indicates enhanced expression compared with the baseline (negative) expression level found in the NHOK cultures.
p16INK4A expression status is based on the Western blotting results (Figure 1B).
Tumourigenic counterpart of NHOK (Park et al, 1995).
Purchased from American Type Culture Collection. The protein expression patterns for these cell lines were based on Munro et al, 1999.
Gift of P. Sacks (Univ. Texas, Houston, TX, USA).
Gift of G. Clayman (Univ. Texas, Houston, TX, USA).
Gift of M. Kastan (Johns Hopkins, Baltimore, MD, USA).